In order to increase the robustness of the global supply chain, CDMOs need to step up and play a larger role than ever before and need…
In Conversation
The Chiesi Culture [has] a sense of closeness, both within our affiliate and to our headquarters. Overall: “We are large enough to cope and small enough…
When it comes to a pandemic like COVID-19, diagnostics is the first priority. You first have to find out where the disease is before you can…
Our priority is improving patient access to our products. The [Mexican] government’s expansion of coverage to those segments of the population that do not have the…
Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting women through the different stages of their life and helping…
It is lamentable that some of the lessons of the previous H1N1 pandemic were forgotten as the world tried to cope with the COVID-19 outbreak. In…
The US market is not really a country market but a continental or regional market, and that is important to understand when a company set up…
Medical innovation, through the development of treatments and ultimately a vaccine, is the only way out from under the shadow of the coronavirus
If the restrictions to parallel trade were always justified, limited in time and scope, and properly implemented, no countries would experience the negative effects of exports,…
In my experience, companies dedicated to particular therapeutic areas seem to be able to learn faster compared to companies with broader portfolios
Any business relationship must be based on trust, aiming towards a win-win approach. If that is present, the sky is the limit
Korea has been, and will continue to be, contributing to the development of robust regulatory science in alignment and harmonization
